Okami Medical Closes $7.2 Million Series D Financing
Okami Medical, Inc. completed a Series D preferred stock offering totaling $7.2 million. The round was led by U.S. Venture Partners. Okami Medical is a spin-out from Inceptus Medical, a medical device incubator in which Dr. Robert Rosenbluth is a principal.
The company is focused on the development of medical devices, including its LOBOTM Vascular Occlusion System, for the occlusion of peripheral vessels.
